ecdysone has been researched along with Breast Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ingermann, AR; Kim, HS; Oh, Y; Tsubaki, J; Twigg, SM; Walker, GE | 1 |
| Atger, M; Baulieu, EE; Best-Belpomme, M; Corvol, P; Courvalin, JC; De Catalogne, D; Mester, J; Milgrom, E; Robel, P; Rochefort, H | 1 |
1 review(s) available for ecdysone and Breast Neoplasms
| Article | Year |
|---|---|
Steroid hormone receptors.
Topics: Androgens; Animals; Breast Neoplasms; Carcinoma; Cell Nucleus; Cytosol; Ecdysone; Estrogens; Female; Genetics; Glucocorticoids; Humans; Leukemia, Lymphoid; Male; Mineralocorticoids; Oviducts; Progesterone; Prostate; Receptors, Cell Surface; Species Specificity; Steroids; Thyroid Hormones; Uterine Neoplasms; Uterus; Vitamin D | 1975 |
1 other study(ies) available for ecdysone and Breast Neoplasms
| Article | Year |
|---|---|
Insulin-like growth factor-binding protein 3 induces caspase-dependent apoptosis through a death receptor-mediated pathway in MCF-7 human breast cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Caspases; Cell Division; Cytochromes c; Cytosol; DNA, Neoplasm; Ecdysone; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Humans; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Mitochondria; Receptor, IGF Type 1; Receptor, IGF Type 2; Signal Transduction; Transfection; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2004 |